Clinical updating study at 3 years on 278 patients treated by modern artificial hair implant technique (automatic biofibre®). Issue 1 (2nd January 2020)

• Record Type: Journal Article
• Authors: Lotti, Torello; Tirant, Michael; Said, A. Rateb; Albzour, Bogdan Morad; Santiago, Mariangela; Agrawal, Manjula; Dutta, Ash; Nguyen, Van Thuong; Vadalà, Mary; Palmieri, B.; Vojvodic, Aleksandra; Fioranelli, Massimo
• Is Part Of: Dermatologic therapy. Volume 33:Issue 1(2020)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2020-01-02
• Subjects: automatic artificial hair implant -- biofibre -- hair implant; Skin -- Diseases -- Periodicals; Dermatology -- Periodicals; 616.5
• DOI: 10.1111/dth.13194
• Languages: English
• ISSNs: 1396-0296

Abstract

Abstract: In this study, we report our multicentric experience of synthetic medical certified polyamide hair implants in male androgenetic, female menopausal, and chronic alopecia. Biofibre hair implantation was performed by means of a standardized, mini‐invasive technique followed by regular postoperative care along 3 years. From May 2015, 278 patients were enrolled and 253 completed the trial; 202 men (79.9%) versus 51 women (20, 1%). The average age was 43(± 4.29); 179 patients (70.1%) had taken previous treatments for alopecia. We evaluated efficacy (as judged by Hamilton scale grading, covered area percent, surgeon, and patient's subjective evaluation) and safety (as judged by adverse events). The overall scalp surface restored with artificial hair (mm 2 spaced) and pre‐postoperative general customers' satisfaction (by Hamilton scale grading) are reported, showing a significant (98, 14%) subjective and objective improvement of the self‐image. Twenty‐two cases (8.75%) declared minor side effects generally counteracted by topical or short course systemic antibiotic and anti‐inflammatory treatment. The average number of implanted fibers was 2, 295 ( SD 2.805; SE 200.9) ranging from 300 to 16, 000. The average duration of pain and tenderness at the implant area was 2.2 days ( SD 4.096; SE 0.2933) ranging from 1 to 20 days. A diagrammatic comparison of the Hamilton scale grading before and after the trial showed a dramatic improvement with the majority of the patients being in Hamilton grade II after implantation.